Skip to main content

Table 5 Multivariate model of time interval from T0 to first treatment (in days)

From: Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment

All patients (N = 283)

Patients with NSCLC only (N = 254)

Characteristic

Beta (days)

p-value

Characteristic

Beta (days)

p-value

RIC

−24 (−35 to −12)

<0.01

RIC

−24 (−37 to −11)

<0.01

Male

−4 (−15 to 8)

0.53

Male

−2 (−14 to 11)

0.77

Age ≥ 75 years

16 (3 to 30)

0.02

Age ≥ 75 years

14 (0–29)

0.05

ECOG ≥ 2a

1 (−16 to 16)

0.98

ECOG ≥ 2a

3 (−14 to 11)

0.77

NSCLC (vs. SCLC)

10 (4 to 43)

0.02

Stage I-II (vs. Stage III-IV)

15 (3–28)

0.02

PET

17 (2 to 31)

0.03

PET

13 (−4 to 29)

0.14

EBUS

2 (−11 to 14)

0.20

EBUS

−1 (−14 to 12)

0.90

Number of non-diagnostic procedures

  

Number of non-diagnostic procedures

  

 0

Reference

 0

Reference

 1

20 (6 to 33)

<0.01

 1

18 (5 to 33)

<0.01

 ≥1

37 (15 to 60)

<0.01

 ≥1

38 (14 to 60)

<0.01

  1. Patients treated with palliative intent, patients receiving treatment outside the McGill University Health Centre, and patients with time to treatment greater than 1 year were excluded from this analysis. aReference category is patients with ECOG of 0 or 1
  2. NSCLC; SCLC